Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. - Wikidata - wikimedia - TriplyDB

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.

http://www.wikidata.org/entity/Q34019930

about

Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study.Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System.Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs Association between anti-TNF-α therapy and all-cause mortality Association between anti-TNF-α therapy and interstitial lung disease.Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients.Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases New methods for determining comparative effectiveness in rheumatoid arthritis The challenges of linking health insurer claims with electronic medical records.Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty.Large Registry Epidemiology in IBD.

P2860

Q34081364-2810F935-331E-4E11-8B65-D9FC85053FF2 Q34756501-342F17A2-F63F-438A-B72A-6CB00BD6865A Q35899264-E8BC0C23-8C31-4628-AE2D-1093512BC0A8 Q36150089-33D98BDC-EF42-47FF-8C38-2FF8346F9C1A Q36174814-EBB834DE-1D26-40A9-8DBB-C7E7287F0FF0 Q36191250-60344A4E-E295-4601-A3B9-B2180EAB5A3F Q36361147-1EF9F2B2-7F2B-4A65-BA7D-6CAE51DE274C Q36590690-A443AA7C-DDB7-461F-B401-8F0BA89E6A5D Q36745669-40B858DE-09C3-45F7-9B02-2259E7416D53 Q36781280-DC664898-3B4D-4067-9CB0-9AC07EAC0798 Q36942914-46A2AF26-2E92-443D-9300-626977BD7F79 Q37171211-354888E2-FF47-40CF-9A39-AA74406859B5 Q37186231-EF556AB8-18B5-4EA6-9835-ADF013B9EB14 Q37274242-44FBD173-1C67-49BE-AB49-85E77778D269 Q38189338-1141E78A-C68E-46F7-9A51-C37CB54A35D0 Q38905074-F9F9A870-ABD0-4171-8CF1-1791BD4B8775 Q39158851-8EDD0F47-90BC-4B1B-9CAA-D21DE690963B Q39783472-55576F18-08FF-4D19-AEC9-0ED81EB7A106 Q40355795-C12540B9-9525-46E8-AD49-BEB9BD627D5D Q49387093-4DCFD699-5FFC-4067-9414-F8B3DD45ADC9

P2860

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.

http://www.wikidata.org/entity/Q34019930

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Study design for a comprehensi ...... tiple healthcare data systems.

@ast

Study design for a comprehensi ...... tiple healthcare data systems.

@en

Study design for a comprehensi ...... tiple healthcare data systems.

@nl

type

label

Study design for a comprehensi ...... tiple healthcare data systems.

@ast

Study design for a comprehensi ...... tiple healthcare data systems.

@en

Study design for a comprehensi ...... tiple healthcare data systems.

@nl

prefLabel

Study design for a comprehensi ...... tiple healthcare data systems.

@ast

Study design for a comprehensi ...... tiple healthcare data systems.

@en

Study design for a comprehensi ...... tiple healthcare data systems.

@nl

P1433

Q34019930-36C3AA7A-1D7D-4A4F-BE0E-74A53FDF6A1B

P1476

Q34019930-028B6287-6A46-43FC-95F6-156BDEAE4193

P2093

Q34019930-040EFF35-8713-4FC3-8A93-3396DC020101

Q34019930-0CB7E146-65F5-4B5F-B2DB-F2FF0470403A

Q34019930-11437051-D525-44EC-BEFE-732BF7B78DE5

Q34019930-29B59155-3EDA-40A2-97EF-349B018C0D38

Q34019930-35DFF452-B941-425D-AFC0-F2A8A1E51323

Q34019930-46BF7174-0F10-4E6A-B1F5-1E6C2C7981EA

Q34019930-5653E780-B6D9-4EA5-BBEA-8CE6A8F25AB7

Q34019930-657DAFF1-793B-4B62-B046-F3A7587B528A

Q34019930-716030F6-93EB-4F8E-87AB-DDF6BBC6CAB6

Q34019930-74BE4E84-D936-4ED4-A4FA-A02DDF1E47CF

P2860

Q34019930-0005E326-6FD6-47E6-8808-3D18978867AD

Q34019930-2CBADB09-52F1-4F2A-B58B-E12EC389A90C

Q34019930-8029A1A3-F804-487A-9636-828856CC22E2

Q34019930-C0BB4DDA-1D91-4ABA-B618-9AD7AE98FD71

Q34019930-CA0AD7BF-85DC-4DCB-9AAC-295B4FFBB27A

P304

Q34019930-D3FF0518-22AC-4CD2-BF93-BB2005775D7A

P31

Q34019930-C94235ED-A70B-4320-9A78-F0F9515E092B

P356

Q34019930-B77F6604-1C4A-4EAD-B539-1F1FE4C4F2CF

P433

Q34019930-9FF1C46F-4423-4095-BE38-CB5D9EEBC556

P478

Q34019930-BAE3EBED-2F1C-48E2-A3CE-EA61213010F1

P577

Q34019930-EE87C33A-7C3E-4751-8A79-E0CF3F97FBF4

P5875

Q34019930-44D41D90-23F2-46EF-BB9D-232781CFABA7

P698

Q34019930-8BA67E41-FBE9-4350-9F21-40B40EDAF7AE

P932

Q34019930-81514FFA-EC55-46B4-818A-FE5C0CE2BF8A

P356

P1433

Pharmacoepidemiology and Drug Safety

P1476

Study design for a comprehensi ...... tiple healthcare data systems.

@en

P2093

Bindee Kuriya

http://www.w3.org/2001/XMLSchema#string

Carlos G Grijalva

http://www.w3.org/2001/XMLSchema#string

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Ed Mitchel

http://www.w3.org/2001/XMLSchema#string

Elizabeth Delzell

http://www.w3.org/2001/XMLSchema#string

James D Lewis

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Curtis

http://www.w3.org/2001/XMLSchema#string

Jeremy Rassen

http://www.w3.org/2001/XMLSchema#string

Joyce Lii

http://www.w3.org/2001/XMLSchema#string

Kenneth G Saag

http://www.w3.org/2001/XMLSchema#string

P2860

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics.

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly.

Estimating causal effects from large data sets using propensity scores.

Evaluating medication effects outside of clinical trials: new-user designs.

P304

1199-1209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.2196

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51635299

http://www.w3.org/2001/XMLSchema#string

P698

21919113

http://www.w3.org/2001/XMLSchema#string

P932

3312584

http://www.w3.org/2001/XMLSchema#string